Skip to content
StingSting Logotyp


Ortrud Medical

Every year there are 3.4 billion attempts at gaining intravenous access in the U.S. and Europe.

Incubate 2016

Despite this being the most common invasive procedure in healthcare, up to every third attempt fails. The failed attempts hurt patients, waste nurses’ time and cost over $20 billion annually. Ortrud Medical is developing an innovative medical device that facilitates intravenous access and decreases the fail rate.

Do you also want to join us?

Become one of the chosen few and be challenged to grow faster with support from some of Sweden’s leading entrepreneurs and former venture capitalists.